Effects of IASTM and Kinesiotaping in Plantar Fascitis
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for a foot condition called plantar fasciitis, which causes pain in the heel and bottom of the foot. The researchers want to see whether a technique called Instrumental Assisted Soft Tissue Mobilization (IASTM) or a method known as Kinesio taping is more effective at improving foot function and quality of life for people suffering from this condition. The study will involve 38 participants, divided into two groups, and is currently looking for volunteers aged 20 to 40 who work on their feet for more than eight hours a day and experience specific pain symptoms related to plantar fasciitis.
To be eligible for the trial, participants must be between 20 and 40 years old, regardless of gender, and have a painful area on the heel that hurts when touched or during the first few steps after resting. However, those with a history of foot or ankle surgery, certain inflammatory diseases, or recent foot injuries may not be able to participate. If you join the trial, you can expect to receive one of the two treatments and provide feedback on how your foot feels and how well you can perform daily activities. This study aims to help improve treatment options for people with plantar fasciitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both genders
- • Age Range of 20-40 years
- • Standing \> 8 hours a day
- • Positive Windlass test
- • Patients who experience pain on medial tuberosity of the calcaneus on palpation.
- • Pain during the initial steps that lessened after a few steps but aggravated by increased activity
- Exclusion Criteria:
- • History of ankle or foot surgery
- • Patients with inflammatory conditions like cancer, rheumatoid arthritis, ankle and foot bursitis.
- • Foot related complications after fracture
- • Patients receiving corticosteroid injections
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Shumaila Parveen, MS-OMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported